A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

NCT07357766 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Cagrisema
DRUG: Placebo CagriSema

Sponsor

Novo Nordisk A/S